Security key
15117B202
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)
CUSIP: 15117B202
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 80,000,000
- Total 13F shares
- 69,594,154
- Share change
- +319,176
- Total reported value
- $2,575,716,559
- Put/Call ratio
- 203%
- Reported price per share
- $37.01
- Number of holders
- 181
- Value change
- +$1,332,092
- Number of buys
- 102
- Number of sells
- 83
Security identity
Holder snapshot
Report period
Q2 2024
Institutions
181
Top holders
10
CLDX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117B202
Recent filing periods:
Ownership snapshot
Top reported holders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
FMR LLC
13D/G signal
—
Evidence rows
15
Latest as of
31 Mar 2024
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Rank 1 holder
FMR LLC
13F
- Ownership
- 12%
- Position
- $408.2M
Rank 2 holder
WELLINGTON MANAGEMENT GROUP LLP
13F
- Ownership
- 9.6%
- Position
- $320.96M
Rank 3 holder
BlackRock Finance, Inc.
13F
- Ownership
- 5.6%
- Position
- $189.37M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
12%
|
$408,201,941
9,726,041 shares
|
— | 31 Mar 2024 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
9.6%
|
$320,963,771
7,647,457 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
5.6%
|
$189,365,451
4,511,924 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4.6%
|
$153,214,927
3,650,582 shares
|
— | 31 Mar 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
3.9%
|
$130,908,081
3,119,087 shares
|
— | 31 Mar 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3.9%
|
$129,571,000
3,087,208 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
181
Shares
69,594,154
Rows available
181
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
196
Q2 2024 holders
181
Holder diff
-15
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend